Advertisement

The association of vagina equivalent dose in 2Gy fraction (EQD2) to late vagina toxicity in patients of cervical cancer treated with WPRT plus IGABT

  • Jintana Ruanla
    Affiliations
    Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
    Search for articles by this author
  • Pooriwat Muangwong
    Affiliations
    Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

    Northern Thailand Radiation Oncology Group, Department of Radiology of Medicine, Chiang Mai University, Chiang Mai, Thailand
    Search for articles by this author
  • Kittikun Kittidachanan
    Affiliations
    Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

    Northern Thailand Radiation Oncology Group, Department of Radiology of Medicine, Chiang Mai University, Chiang Mai, Thailand
    Search for articles by this author
  • Damrongsak Tippanya
    Affiliations
    Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
    Search for articles by this author
  • Warit Thongsuk
    Affiliations
    Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
    Search for articles by this author
  • Anupong Kongsa
    Affiliations
    Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
    Search for articles by this author
  • Razvan M. Galalae
    Affiliations
    MedAustron, Center for Carbon Ion Therapy and Research, Wiener Neustadt, Vienna, Austria

    Department of Radiotherapy, Faculty of Medicine, Christian-Albrechts University, Kiel, Germany
    Search for articles by this author
  • Ekkasit Tharavichitkul
    Correspondence
    Corresponding author: The Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Tel: +66-53-935456.
    Affiliations
    Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

    Northern Thailand Radiation Oncology Group, Department of Radiology of Medicine, Chiang Mai University, Chiang Mai, Thailand
    Search for articles by this author

      ABSTRACT

      Aim

      To evaluate the associations of vaginal dose parameters and incidence of vaginal stenosis in patients with cervical cancer treated with image-guided brachytherapy (IGBT).

      Materials and Methods

      Fifty-four patients with cervical cancer treated with IGBT were included. The vagina contouring was done on previously treated CT images and the vaginal dose points were marked. The cumulative dose in EQD2 from EBRT and IGBT was calculated for both aspects and the vaginal toxicity was evaluated.

      Results

      At median follow-up time of 18.5 months, grade 2 or higher vaginal stenosis was observed in 24% of patients. On univariate analysis, parameters that were associated with ≥ grade 2 vaginal stenosis were age, mean dose of lateral 5 mm vagina, dose at PIBS-2 cm, mid vaginal D0 .03cc, mid vagina D1cc, lower vagina D0.03cc, lower vagina D0.1cc, lower vagina D1cc and lower vagina D2cc. On multivariate analysis, the significant parameters were age > 68.5 years old (P = 0.038), mean dose of lateral 5-mm (P = 0.034), and dose at PIBS-2 cm (P = 0.042).

      Conclusions

      Age > 68.5 years old, mean dose of lateral 5 mm vagina and dose at PIBS-2 cm were associated with grade 2 or higher vaginal stenosis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brachytherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sung H
        • Ferlay J
        • Siegel RL
        • et al.
        Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2021; 71: 209-249
        • Chino J
        • Annunziata CM
        • Beriwal S
        • et al.
        The ASTRO clinical practice guidelines in cervical cancer: optimizing radiation therapy for improved outcomes.
        Gynecol Oncol. 2020; 159: 607-610
        • Haie-Meder C
        • Pötter R
        • Van Limbergen E
        • et al.
        Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆(I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.
        Radiother oncol. 2005; 74: 235-245
        • Pötter R
        • Haie-Meder C
        • Van Limbergen E
        • et al.
        Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
        Radiother Oncol. 2006; 78: 67-77
        • Sturdza A
        • Pötter R
        • Fokdal LU
        • et al.
        Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
        Radiother Oncol. 2016; 120: 428-433
        • Pötter R
        • Tanderup K
        • Schmid MP
        • et al.
        MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
        Lancet Oncol. 2021; 22: 538-547
        • Kirchheiner K
        • Nout RA
        • Tanderup K
        • et al.
        Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo) therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
        Int J Radiat Oncol Biol Phys. 2014; 89: 88-95
        • Hofsjö A
        • Bohm-Starke N
        • Blomgren B
        • et al.
        Radiotherapy-induced vaginal fibrosis in cervical cancer survivors.
        Acta Oncol. 2017; 56: 661-666
        • Kumbhaj PR
        • Sharma R
        • Bhatnagar A
        • Saini PK.
        Sexual functioning & quality of life in cervical cancer survivors after surgery and radiotherapy.
        Natl J Med Res. 2014; 4: 116-118
        • Rahman Z
        • Singh U
        • Qureshi S.
        • et al.
        Assessment of quality of life in treated patients of cancer cervix.
        J Midlife Health. 2017; 8: 183-188
        • Susko M
        • Craciunescu O
        • Meltsner S
        • et al.
        Vaginal dose is associated with toxicity in image guided tandem ring or ovoid-based brachytherapy.
        Int J Radiat Oncol Biol Phys. 2016; 94: 1099-1105
        • Westerveld H
        • Kirchheiner K
        • Nout RA
        • et al.
        Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: an EMBRACE-I sub-study.
        Radiother oncol. 2002; 168: 8-15
        • Kirchheiner K
        • Nout RA
        • Lindegaard JC
        • et al.
        Dose–effect relationship and risk factors for vaginal stenosis after definitive radio (chemo) therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
        Radiother oncol. 2016; 118: 160-166
        • Murakami N
        • Kasamatsu T
        • Sumi M
        • et al.
        Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies.
        Radiat Oncol. 2014; 9: 1-8
        • Kim MJ
        • Kim MS
        • Park IY
        • Kim SJ.
        Determinants of vagina by computed tomography in Korean women.
        Int Urogynecol J. 2009; 20: 677-680
        • Fidarova E
        • Berger D
        • Schüssler S
        • et al.
        Dose volume param- 403 eter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treat- 405 ment protocol with very high brachytherapy doses.
        Radiother Oncol 406. 2010; 97: 76-79
        • Wilke L
        • Andratschke N
        • Blanck O
        • et al.
        ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams.
        Strahlenther Onkol. 2019; 195: 193-198
      1. ICRU Report 89. Prescribing, Recording, and reporting brachytherapy for cancer of the cervix. International Commission on Radiation Units and Measurements: 2013.

        • Westerveld H
        • Pötter R
        • Berger D
        • et al.
        Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.
        Radiother Oncol. 2013; 107: 99-105
        • Yoshida K
        • Yamazaki H
        • Nakamura S
        • et al.
        Comparisons of late vaginal mucosal reactions between interstitial and conventional intracavitary brachytherapy in patients with gynecological cancer: speculation on the relation between pallor reaction and stenosis.
        Anticancer Res. 2013; 33: 3963-3968
        • Westerveld H
        • de Leeuw A
        • Kirchheiner K
        • et al.
        Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.
        Radiother Oncol. 2016; 120: 420-427
        • Brand AH
        • Bull CA
        • Cakir B
        Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix.
        Int J Gynecol Cancer. 2006; 16: 288-293
        • Tharavichitkul E
        • Jayavasti R
        • Galalae RM
        • et al.
        The assiciations for Vaginal Point Doses of Vaginal Stenosis in Image-Guided Brachytherapy.
        J Cancer Ther. 2014; 5 (2014): 823-829